Genomic Evolution of Metastasis in Gastric Cancer

A Benefit Population Atlas of nICT Versus nCT for LAGC

NCT07098104 ·Status: COMPLETED

the Optimal Surveillance Frequency for Stage II/III Gastric Cancer

NCT05465993 ·Status: COMPLETED

Microbiota and Metabolomics of Intestinal Type of Gastric Cancer

NCT06079554 ·Status: RECRUITING

Methylation Analysis of Circulating Tumor DNA in Gastric Cancer

NCT04511559 ·Status: UNKNOWN

Transcriptomic Signatures in Gastric Adenocarcinoma

NCT05319392 ·Status: UNKNOWN

Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study

NCT01558011 ·Status: TERMINATED ·Phase: PHASE2

A Multi-omics-based Metabolic Typing Study of Gastric Cancer

NCT06134011 ·Status: ACTIVE_NOT_RECRUITING

HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

NCT05300945 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy

NCT06277453 ·Status: ACTIVE_NOT_RECRUITING

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

NCT04931420 ·Status: WITHDRAWN ·Phase: PHASE2

Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer

NCT07098026 ·Status: RECRUITING ·Phase: NA

Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy

NCT06202781 ·Status: RECRUITING

Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

NCT03425058 ·Status: COMPLETED

Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC

NCT06684158 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis

NCT04440605 ·Status: UNKNOWN

The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study

NCT02583659 ·Status: UNKNOWN

Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis

NCT06109805 ·Status: COMPLETED

Gastric Cancer Registry for Epidemiology and Molecular Risk Factor

NCT03046745 ·Status: UNKNOWN

Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer

NCT01625702 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer

NCT00042510 ·Status: COMPLETED ·Phase: PHASE2

Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

NCT02528110 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

NCT03399253 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery

NCT07149181 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer

NCT05230771 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer

NCT05000554 ·Status: RECRUITING ·Phase: PHASE2